Recent studies of prostate cancer suggest an enhanced risk associated with prior vasectomy. The incidence of prostate cancer in middle-aged men in western Washington has increased by about 60% over the past decade, and vasectomy is a widely used method of contraception in this geographic area. If findings from recent studies are confirmed, this could represent a major public health problem. The primary aims of the proposed study are to determine whether or not vasectomy is related to an increased risk of prostate cancer, and to assess whether there is evidence of a possible latent effect of vasectomy. To study the relationship between vasectomy and prostate cancer, we propose a population-based case-control study of 700 cases and 700 controls. Eligible cases will be men 40-64 years of age who are diagnosed with incident prostate cancer between January 1, 1993 and December 31, 1996 and who are residents of King county in northwestern Washington State. Cases will be ascertained through the Seattle-Puget Sound SEER Cancer Registry. Controls will be identified through random digit dialing, and will be frequency matched to cases on age (same 5-year group) and county of residence. Study subjects will be interviewed in person. Information will be obtained on history of vasectomy, reproductive and sexual history, medical history, demographic variables, and health behaviors such as smoking and the prevalence of use of screening procedures for the early detection of prostate cancer. Data analysis will include descriptive, stratified, and multivariate analyses. The relative risk of prostate cancer in relation to vasectomy will be estimated, after accounting for the potential confounding effects of other exposure variables.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA056678-05
Application #
2330813
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Patel, Appasaheb1 R
Project Start
1993-02-05
Project End
2000-01-31
Budget Start
1997-02-01
Budget End
2000-01-31
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Dai, James Y; Wang, Bo; Wang, Xiaoyu et al. (2018) Vigorous physical activity is associated with metastatic-lethal progression in prostate cancer and differential tumor DNA methylation in the CRACR2A gene. Cancer Epidemiol Biomarkers Prev :
Zhao, Shanshan; Leonardson, Amy; Geybels, Milan S et al. (2018) A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer. Prostate :
Geybels, Milan S; Fang, Min; Wright, Jonathan L et al. (2017) PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles. Oncotarget 8:84338-84348
Karyadi, Danielle M; Geybels, Milan S; Karlins, Eric et al. (2017) Whole exome sequencing in 75 high-risk families with validation and replication in independent case-control studies identifies TANGO2, OR5H14, and CHAD as new prostate cancer susceptibility genes. Oncotarget 8:1495-1507
Geybels, Milan S; McCloskey, Karen D; Mills, Ian G et al. (2017) Calcium Channel Blocker Use and Risk of Prostate Cancer by TMPRSS2:ERG Gene Fusion Status. Prostate 77:282-290
Jhun, Min A; Geybels, Milan S; Wright, Jonathan L et al. (2017) Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort. Oncotarget 8:43035-43047
Rubicz, Rohina; Zhao, Shanshan; Wright, Jonathan L et al. (2017) Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer. Mol Oncol 11:140-150
Zhao, Shanshan; Geybels, Milan S; Leonardson, Amy et al. (2017) Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer. Clin Cancer Res 23:311-319
Luedeke, Manuel; Rinckleb, Antje E; FitzGerald, Liesel M et al. (2016) Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status. Hum Mol Genet 25:5490-5499
Rizzardi, Anthony E; Zhang, Xiaotun; Vogel, Rachel Isaksson et al. (2016) Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor ?2 immunohistochemistry in prostate cancer. Diagn Pathol 11:63

Showing the most recent 10 out of 98 publications